MicroTech Medical (Hangzhou) Co., Ltd. Sustainability Profile
MicroTech Medical (Hangzhou) Co., Ltd., a leading player in the medical device industry, is headquartered in Hangzhou, China. Founded in 2000, the company has established itself as a pioneer in the development and manufacturing of innovative diabetes management solutions, including insulin delivery systems and continuous glucose monitoring devices. With a strong presence in both domestic and international markets, MicroTech Medical is renowned for its commitment to quality and technological advancement. The company’s core products are distinguished by their user-friendly design and precision, catering to the needs of patients and healthcare professionals alike. Recognised for its significant contributions to diabetes care, MicroTech Medical continues to enhance its market position through ongoing research and development, solidifying its reputation as a trusted name in the medical technology sector.
DitchCarbon Score
How does MicroTech Medical (Hangzhou) Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MicroTech Medical (Hangzhou) Co., Ltd.'s score of 28 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
MicroTech Medical (Hangzhou) Co., Ltd.'s reported carbon emissions
In 2023, MicroTech Medical (Hangzhou) Co., Ltd. reported total carbon emissions of approximately 1,609,670 kg CO2e, comprising 8,370 kg CO2e from Scope 1 and 1,601,900 kg CO2e from Scope 2 emissions. This marks a significant increase from 2022, when the company emitted about 1,129,470 kg CO2e, with Scope 1 emissions at 820 kg CO2e and Scope 2 emissions at 1,129,380 kg CO2e. MicroTech Medical has set ambitious climate commitments, aiming for net zero emissions for both direct (Scope 1) and indirect (Scope 2) greenhouse gas emissions by 2050. Additionally, the company has established near-term reduction targets, intending to cut Scope 1 emissions by 50% and Scope 2 emissions by 40% from a 2021 baseline by 2030. These initiatives reflect a proactive approach to climate action, aligning with industry standards for sustainability and emissions reduction. The company does not currently report Scope 3 emissions, indicating a focus on direct and indirect emissions within its operational control. Overall, MicroTech Medical's commitments and targets demonstrate a clear pathway towards reducing its carbon footprint and contributing to global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 820 | 0,000 |
| Scope 2 | 1,129,380 | 0,000,000 |
| Scope 3 | - | - |
How Carbon Intensive is MicroTech Medical (Hangzhou) Co., Ltd.'s Industry?
How Carbon Intensive is MicroTech Medical (Hangzhou) Co., Ltd.'s Location?
MicroTech Medical (Hangzhou) Co., Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
MicroTech Medical (Hangzhou) Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
